Drug Trial Radar · NCT05767047
A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
Last checked: Nov 20, 2026Latest source record: Nov 4, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Mar 23, 2023
Primary completion
Mar 17, 2036
Study completion Mar 17, 2036
Sponsor
- Lead sponsor
- AmgenAmgen (AMGN)
- Sponsor type
- Industry
- First posted
- Mar 14, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Not applicable (single group)
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 5 years, up to 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to evaluate the long-term safety of apremilast in subjects 2 years of age or older with oral ulcers associated with Behçets disease or 5 years of age or older with active juvenile psoriatic arthritis that have completed Study 20190530 or Study 20190529.
Conditions
- Behçet's Disease
- Juvenile Psoriatic Arthritis
Interventions
ApremilastDrug
Oral tablets or liquid suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants with Adverse EventsTime frame: Up to approximately 4 years
- Columbia-Suicide Severity rating Scale (C-SSRS)Time frame: Up to approximately 4 years
- Tanner StagingTime frame: Up to approximately 4 years
- Change from Baseline in Body WeightTime frame: Up to approximately 4 years
- Change from Baseline in HeightTime frame: Up to approximately 4 years
- Change from Baseline in Body Mass Index (BMI)Time frame: Up to approximately 4 years
- Number of Participants with Clinically Significant Changes in Vital SignsTime frame: Up to approximately 4 years
- Number of Participants with Clinically Significant Changes in Laboratory ParametersTime frame: Up to approximately 4 years
Locations
7 sites in 4 countries. Site status is shown where the registry gives one.
General Hospital of Thessaloniki Ippokrateio
Thessaloniki, Greece · Recruiting
Meir Medical Center
Kfar Saba, Israel · Recruiting
Hospital Universitario Ramon y Cajal
Madrid, Spain · Recruiting
Hospital Universitari i Politecnic La Fe
Valencia, Valencia, Spain · Recruiting
Hacettepe Universitesi Tip Fakultesi Hastanesi
Ankara, Turkey (Türkiye) · Recruiting
Istanbul Universitesi Cerrahpasa Tip Fakultesi
Istanbul, Turkey (Türkiye) · Recruiting
Umraniye Egitim ve Arastirma Hastanesi
Istanbul, Turkey (Türkiye) · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.